Targeting the Default Mode Network: A TMS-fMRI Study
2 other identifiers
interventional
30
1 country
1
Brief Summary
In post-traumatic stress disorder (PTSD), intrusive, traumatic, autobiographical memories lead to anxiety symptoms. Recent work suggests a new repetitive pulse transcranial magnetic stimulation (rTMS) brain target that might bring relief. Since this proposed target is not well understood, the goal of the study is to use functional magnetic resonance imaging (fMRI) to identify the brain regions and networks that change with rTMS stimulation at this target area in PTSD patients. Ultimately, this would lead to a personalized approach to rTMS treatment of PTSD based on brain imaging that can be used in a future clinical trial. Participants will be asked to complete psychological testing and questionnaires as well as an initial MRI and two separate TMS-fMRI sessions. Total participation time across all visits is estimated to be five to six hours. Research participation will take place at VA Palo Alto as well as at Stanford University.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 2, 2022
CompletedFirst Posted
Study publicly available on registry
December 12, 2022
CompletedStudy Start
First participant enrolled
August 2, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2025
CompletedApril 3, 2024
April 1, 2024
1.5 years
December 2, 2022
April 1, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Resting-State fMRI Connectivity
Measure of the connectivity between the left 8Av and DMN nodes.
During the resting state fMRI (rsfMRI) session
FMRI BOLD Response
Measure of the immediate activation (blood-oxygen-level-dependent change) in the brain regions related to PTSD following transcranial magnetic stimulation using interleaved TMS and fMRI.
During the TMS-fMRI session
Changes in Connectivity after cTBS
Measure of the connectivity changes between the left 8Av and DMN nodes from the initial resting state fMRI and a resting state fMRI collected immediately following inhibitory TMS (cTBS).
During the TMS-fMRI session
Study Arms (1)
TMS-fMRI
EXPERIMENTALParticipants will undergo simultaneous TMS-fMRI as part of this study. There will be two locations stimulated: one control region and one target region. Participants will be randomized with respect to the order of receiving stimulation at the locations, but all participants will receive stimulation at both locations as part of the study. All participants will be considered as one group but order effects will be evaluated as an explanatory variable.
Interventions
Participants will undergo simultaneous TMS and fMRI
Eligibility Criteria
You may qualify if:
- Between 18 and 55 years of age
- Ability to maintain a Motor Threshold (MT) with single pulse TMS
- Ability to safely and comfortably undergo an MRI and TMS
- Able to read, verbalize, understand, and voluntarily sign the Informed Consent Form prior to participating in any study-specific procedures or assessments.
- PTSD diagnosis according to the DSM 5, as determined by the Clinician administered PTSD scale (CAPS-5) criteria.
- Commitment to maintaining a stable medication regimen between the two fMRI sessions
You may not qualify if:
- Inability to safely and comfortably undergo an MRI. MRI safety will be determined by the center where MRI's are collected.
- Significant dementia as determined by the Montreal Cognitive Assessments (MoCA)
- Being in urgent need of care that would make participation impossible
- Currently taking medications that increase the risk of seizure or influence hemodynamic response
- Presence of any other condition that has the potential to prevent study completion and/or have a confounding effect on the interpretation of results.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Allyson Rosenlead
- National Institute of Mental Health (NIMH)collaborator
Study Sites (1)
VA Palo Alto
Palo Alto, California, 94304, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Allyson C Rosen, Ph.D.
PAVIR/Palo Alto VAHCS/Stanford University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Masking Details
- order of presentation is randomized
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Neuropsychologist
Study Record Dates
First Submitted
December 2, 2022
First Posted
December 12, 2022
Study Start
August 2, 2023
Primary Completion
January 31, 2025
Study Completion
January 31, 2025
Last Updated
April 3, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share
Researchers will not share the IPD without VA permission. The research team has requested guidance and if allowed, IPD may be shared, but for now there is no plan to share IPD. This statement will be updated if this changes.